An enhancer factor defect in a mutant Burkitt lymphoma cell line

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• The Burkitt lymphoma cell line Raji is a well-characterized model for B-cell research.
• RJ 2.2.5 is a mutant subline of Raji, specifically selected for its immunophenotypic properties.
• Defects in major histocompatibility complex (MHC) class II antigen presentation can impair immune responses.

Purpose of the Study:

• To investigate the molecular basis for the absence of MHC class II antigens on the surface of RJ 2.2.5 cells.
• To identify the specific regulatory factor that is defective in RJ 2.2.5 cells.
• To elucidate the role of this factor in the transcriptional regulation of MHC class II genes.

Main Methods:

• Utilized immunoselection techniques to generate and characterize the RJ 2.2.5 cell line.
• Performed molecular analyses to assess gene expression and regulatory element activity.
• Investigated the function of a specific regulatory factor crucial for MHC class II gene enhancer activity.

Main Results:

• RJ 2.2.5 cells exhibit a transcriptional defect leading to the failure of MHC class II antigen display.
• A specific regulatory factor, essential for MHC class II gene enhancer function, was found to be defective in RJ 2.2.5 cells.
• The identified factor plays a critical role in controlling the expression of MHC class II genes.

Conclusions:

• The study successfully identified a defective regulatory factor in RJ 2.2.5 cells.
• This defect directly explains the lack of MHC class II antigen expression at the cell surface.
• Understanding this regulatory mechanism provides insights into the control of MHC class II gene expression in B-lymphoma cells.